What are the recent financial highlights of SENORES PHARMACEUTICALS L?

SENORES PHARMACEUTICALS L recently reported a total revenue of ₹386.48 Cr and a net profit margin of 14.66%. These metrics reflect the company’s consistent financial performance.

What are the key financial metrics of SENORES PHARMACEUTICALS L?

Key financial metrics include a trailing P/E ratio of 40.215622, forward P/E of , book value of ₹87.628, price-to-book ratio of 5.640321, and a market capitalization of ₹22.76 billion.

What does SENORES PHARMACEUTICALS L do?

Senores Pharmaceuticals Limited develops, manufactures, and sells, pharmaceutical products in India, the United States, Canada, and internationally. The company offers tablets, capsules, liquids, dry syrups, oral rehydration solutions, active pharmaceutical ingredients, and critical care injectables, including antibiotics, anti-bacterial, anti-fungal, and blood line. It also exports its products. The company provides consulting and licensing services. Senores Pharmaceuticals Limited was incorporated in 2017 and is based in Ahmedabad, India.

Loading...

₹ 0 0.00%

Loading... BSE: Loding... NSE: Senores

About

Loading... ^[1]

Website BSE NSE

Market Cap ₹ 0 Cr.
Current Price ₹ 0
High / Low ₹ 0 / 0
Stock P/E
Dividend Yield 0 %
ROE 0 %
EPS 0
P/B Ratio 0
Net Profit Margin 0 %
Debt to Equity 0
ROCE 0 %
Interest Coverage 0 %

Stock News - Senores

Latest updates related to Senores

Sr No.	Title	Sentiment
1	Stocks to watch, December 30: IT stocks, Gujarat Fluorochemicals, Coforge, JSW Energy, Hero MotoCorp, Senores Pharmaceuticals, and more Upstox	🔄
2	IPO GMP, listing date: Ventive Hospitality, Senores Pharmaceuticals to Carraro India - what grey market signals? Mint	🔄
3	IPO GMP, listing date: Ventive Hospitality, Senores Pharmaceuticals to Carraro India - what grey market signals? Mint	🔄
4	December IPO Frenzy Continues: Carraro India, Senores Pharmaceuticals, and Ventive Hospitality Set to Debut on Indian Stock Exchanges on December 20, 2024 Groww	🔄
5	Senores, Ventive, Carraro IPOs to close: Check subscription status, GMP Business Standard	🔄
6	Senores Pharma, Ventive Hospitality debut at premium; Carraro shares list at 8% discount Business Today	🔄
7	Senores Pharma to acquire 14 ANDAs from Dr Reddy's Laboratories The Economic Times	🔄
8	Senores Pharma eyes strong growth in contract manufacturing, revenue boost from Dr Reddy’s deal CNBCTV18	🔄
9	Senores Pharmaceuticals acquires 14 ANDAs from Dr Reddy’s Healthcare Radius	🔄
10	Senores Pharma up 7% on acquiring 14 ANDAs from Dr. Reddy's Laboratories Business Standard	🔄

Peer Comparison

Macro Industry: Loading.. | Sector: Loading.. | Industry: Loading.. | Basic Industry: Loading..

Loading peers table...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Loading data...

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Loading Profit & Loss data...

Compounded Sales Growth
10 Years:
5 Years:
3 Years:
TTM:

Compounded Profit Growth
10 Years:
5 Years:
3 Years:
TTM:

Stock Price CAGR
10 Years:
5 Years:
3 Years:
1 Year:

Return on Equity
10 Years:
5 Years:
3 Years:
Last Year:

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Shareholding Pattern

Numbers in percentages

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Delivery Data

Insider Data

Technical Data

Static Application Security Testing

Documents

Announcements

Annual reports

Right Issue

Credit ratings

Concalls

Explore More Stocks

DCMFINSERV SURANAT&P MYMUDRA HDFCBANK EIHAHOTELS PREMIUM EQUIPPP EDUCOMP DBSTOCKBRO TBZ